Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D

Author(s): Hollis BW

Abstract

It has been more than 3 decades since the first assay assessing circulating 25-hydroxyvitamin D [25(OH)D] in human subjects was performed and led to the definition of "normal" nutritional vitamin D status, i.e., vitamin D sufficiency. Sampling human subjects, who appear to be free from disease, and assessing "normal" circulating 25(OH)D levels based on a Gaussian distribution of these values is now considered to be a grossly inaccurate method of identifying the normal range. Several factors contribute to the inaccuracy of this approach, including race, lifestyle habits, sunscreen usage, age, latitude, and inappropriately low dietary intake recommendations for vitamin D. The current adult recommendations for vitamin D, 200-600 IU/d, are very inadequate when one considers that a 10-15 min whole-body exposure to peak summer sun will generate and release up to 20,000 IU vitamin D-3 into the circulation. We are now able to better identify sufficient circulating 25(OH)D levels through the use of specific biomarkers that appropriately increase or decrease with changes in 25(OH)D levels; these include intact parathyroid hormone, calcium absorption, and bone mineral density. Using these functional indicators, several studies have more accurately defined vitamin D deficiency as circulating levels of 25(OH)D < or = 80 nmol or 32 microg/L. Recent studies reveal that current dietary recommendations for adults are not sufficient to maintain circulating 25(OH)D levels at or above this level, especially in pregnancy and lactation.

Similar Articles

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis

Author(s): Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L

Epstein-Barr virus in pediatric multiple sclerosis

Author(s): Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B

Vitamin D and latitude as environmental factors in multiple sclerosis

Author(s): Niino M, Miyazaki Y, Fukazawa T, Kikuchi S

Differential twin concordance for multiple sclerosis by latitude of birthplace

Author(s): Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, et al.

The genetics of multiple sclerosis: An up-to-date review

Author(s): Gourraud PA, Harbo HF, Hauser SL, Baranzini SE

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

Author(s): Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis

Author(s): Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Incidence and prevalence of multiple sclerosis in southeastern Iran

Author(s): Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S

Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time

Author(s): Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.

Estimation of the dietary requirement for vitamin D in healthy adults

Author(s): Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, et al.

Nutritional status and anthropometric measurements of patients with multiple sclerosis

Author(s): Saka M, Saka M, Koseler E, Metin S, Bilen S, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis

Author(s): Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, et al.

Dietary intake of vitamin D during adolescence and risk of multiple sclerosis

Author(s): Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, et al.

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, et al.